A Post-Marketing Observational Study of VYXEOS™

Clinical trial NCT03526926 · COMPLETED

Trial details

NCT number: NCT03526926
Sponsor: Jazz Pharmaceuticals
Status: COMPLETED
Study type: OBSERVATIONAL

Acute Myeloid Leukemia With Myelodysplasia-Related Changes Therapy-Related Acute Myeloid Leukemia

Start date: 2018-10-23
Primary completion: 2019-10-26
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.